ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) has been identified as a high-growth momentum stock that aligns with Mark Minervini’s Trend Template criteria. The company, which specializes in immune medicine diagnostics and therapeutics, demonstrates strong technical and fundamental characteristics that make it an interesting candidate for growth-focused investors.
Why ADPT Fits the Minervini Trend Template
Minervini’s strategy focuses on stocks in strong uptrends with accelerating fundamentals. ADPT meets these technical criteria:
-
Price Above Key Moving Averages:
- Current price ($10.32) is above the 50-day ($8.75), 150-day ($7.59), and 200-day ($6.88) moving averages.
- The 50-day MA is above both the 150-day and 200-day MAs, confirming bullish momentum.
- The 200-day MA is trending upward, reinforcing long-term strength.
-
Strong Relative Strength:
- ADPT’s relative strength (CRS) is 98.42, meaning it outperforms nearly 99% of all stocks.
- It leads its industry (Life Sciences Tools & Services), outperforming 96% of peers.
-
Price Near 52-Week High:
- The stock is trading within 5% of its 52-week high ($10.87), a sign of sustained momentum.
- It has surged 230% over the past year, indicating strong investor interest.
High Growth Fundamentals
Beyond technical strength, ADPT exhibits accelerating growth metrics:
-
Earnings Growth:
- Quarterly EPS growth (Q2Q) is up 39.4%, with consistent beats in the last four quarters.
- Annual EPS growth (TTM) improved by 26.7%, showing sustained profitability trends.
-
Revenue Momentum:
- Quarterly revenue growth rose 25.2%, with four consecutive beats averaging 11.1% above estimates.
- Analysts have raised next-year EPS estimates by 9.9% in the last three months.
-
Free Cash Flow Improvement:
- FCF per share grew 54.4% year-over-year, reflecting better operational efficiency.
Technical Outlook
According to ChartMill’s technical report, ADPT scores a perfect 10/10 on technical health, with both short-term and long-term trends positive. However, the setup quality is rated 6/10, suggesting investors may want to wait for a consolidation before entering. Key support levels are at $10.16–$10.23 and $8.75–$8.94.
For a deeper technical breakdown, review the full ADPT technical report.
Our High Growth Momentum + Trend Template screener lists more high-growth stocks meeting Minervini’s criteria.
Disclaimer
This is not investing advice. Always conduct your own research and consider risk management before making investment decisions.
